Skip to content

Ragosa Mark Insider Trading -- Recent SEC Form 4 Transactions

Ragosa Mark (CIK 1835458) reported 46 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-11-03). Recent activity: Buy KNSA (5,388 shares), Sell KNSA (220 shares), Buy KNSA (12,123 shares), Buy KNSA (9,636 shares), Sell KNSA (14,027 shares). Source: SEC Form 4.

DateCompanyRoleTypeSharesValue
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy5,388$59,807
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell220$20,682
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy12,123$145,112
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy9,636$171,135
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell14,027$1.3M
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell10,502$966,499
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell12,034$1.1M
2026-11-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy9,636$103,683
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell4,404$349,149
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy2,694$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy1,750$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy1,591$0
2026-09-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy3,069$0
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy2,694$0
2026-04-08Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell1,303$63,769
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy5,187$0
2026-04-03Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell2,510$120,806
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy2,036$46,604
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy10,513$186,711
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy10,360$277,026
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell17,981$819,574
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERSell18,741$866,584
2026-03-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy13,813$249,463
2026-02-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy2,471$41,760
2026-02-11Kiniksa Pharmaceuticals International, plc (KNSA)CHIEF FINANCIAL OFFICERBuy8,374$108,611

Source: SEC Form 4 filings · as of 2026-11-03